Real-time enrollment status for this prostatic neoplasms clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 6:45 PM UTC
| NCT Number | NCT05616650 |
| Recruiting Status | Recruiting |
| Condition | Prostatic Neoplasms |
| Phase | PHASE2 |
| Target Enrollment | 42 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 16, 2026 (3 days ago) |
As of July 19, 2026: Clinical trial NCT05616650 is currently recruiting participants. This phase2 study for prostatic neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05616650 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05616650 was last updated 3 days ago (July 16, 2026). HelloStudys verifies this status automatically.